Site Map
Main Menu
- Home
- About Traq
- About Us
- About Daryl Gouthro
- About Laurie Beitel
- About Kieran Biggins
- About Gwen Clarke
- About Lee Grabner
- About Sharon Herd
- About Debra Lane
- About Pat Letendre
- About Heather Mah
- About Dianne Powell
- About Maureen Wyatt
- About Cheryl Cooper
- About Chad Milford
- About Ray Berger
- About Penny Chan
- About Ahmed Coovadia
- About Kathleen Eckert
- About Kate Gagliardi
- About Nancy Heddle
- About Lisa Merkley
- About Wendy Owens
- About Veronika Pulley
- About Ann Wilson
- About Marilyn Collins
- Contact
- Terms of Use & Privacy Policies
- Style Guide (Example Only)
- About Us
- Guidelines & Standards
- Case Studies
- Level A Case Studies
- Case A8: Severe Hemolytic Transfusion Reaction Involving a Student
- Case Study A8 Discussion Part 1 - Root Cause Analysis
- Case Study A8 Discussion Part 2 - Test Errors
- Case Study A8 Discussion Part 3 - Risk Management
- Case Study A8 Discussion Part 4 - Supervision of Students
- Case Study A8 Discussion Part 5 - Regulations and Standards
- Case Study A8 - Quiz Answers
- Case Study A8 - Supervision of Students - Answer (Question 1)
- Case Study A8 - Supervision of Students - Answer (Question 2)
- Case Study A8 - Root Cause Analysis - Answer (Question 1)
- Case Study A8 - Root Cause Analysis - Answer (Question 2)
- Case Study A8 - Risk Management - Answer (Question 1)
- Case Study A8 - Risk Management - Answer (Question 2)
- Case Study A8 - Regulations & Standards - Answer (Question 1)
- Case Study A8 - Testing Errors - Answer
- Case A7: Inter-facility Transportation of RBCs
- Case Study A7 - Quiz Answers
- Case Study A7 - Discussion
- Case Study A7 - Discussion - Answer (Question 1)
- Case Study A7 - Discussion - Answer (Question 2)
- Case Study A7 - Discussion - Answer (Question 3)
- Case Study A7 - Discussion - Answer (Question 4)
- Case Study A7 - Discussion - Answer (Question 5)
- Case Study A7 - Discussion - Answer (Question 6)
- Case Study A7 - Discussion - Answer (Question 7)
- Case A6: Elderly Patient With a Difficult Antibody Combination
- Case Study A6 - Initial Pretransfusion Test Results
- Case Study A6 - Antibody Identification - Panel #1
- Table C.T.008: Exclusion of Antibodies
- Case Study A6 - Antibody Identification - Panel #2
- Case Study A6 - Antigen Phenotyping
- Case Study A6 - Antibody Identification - Panel #3
- Case Study A6 - Summary
- Case Study A6 - Answer (Question 1)
- Case Study A6 - Answer (Question 2)
- Case Study A6 - Answer (Question 3)
- Case Study A6 - Answer (Question 4)
- Case A6 - Answer (Panel 1- Question #1)
- Case A6 - Answer (Panel 1- Question #2)
- Case A6 - Answer (Panel 2- Question #1)
- Case A6 - Answer (Panel 2- Question #2)
- Case A6 - Answer (Panel 3- Question #1)
- Case A6 - Answer (Panel 3- Question #2)
- Case A5: Adverse Reaction to Intravenous Rh Immune Globulin in a Patient with ITP
- Case Study A5 - Initial Pretransfusion Test Results
- Case Study A5 - Antibody Screen and DAT Results
- Case Study A5 - Antibody Identification
- Case Study A5 - Summary
- Case Study A5 - Answer (Question 1)
- Case Study A5 - Answer (Question 2)
- Case Study A5 - Answer (Question 3)
- Case Study A5 - Answer (Question 4)
- Case Study A5 - Answer (Question 5)
- Case Study A5 - Answer (Question 6)
- Case Study A5 - Answer (Question 7)
- Case Study A5 - Answer (Question 8)
- Case Study A5 - Answer (Question 9)
- Case Study A5 - Answer (Question 10)
- Case A5 - Answer Q#1 (Eluate Panel)
- Case A5 - Answer Q#2 (Eluate Panel)
- Case A5 - Answer Q#3 (Eluate Panel)
- Case A5 - Answer Q#4 (Eluate Panel)
- Case A4: Positive DAT in a Recently Transfused Nonagenarian
- Case Study A4 - Post-Transfusion Crossmatch Results
- Case Study A4 - Initial Antibody Identification Results
- Case Study A4 - Direct Antiglobulin Test
- Case Study A4 - Patient's Phenotyping
- Case Study A4 - Antibody Identification (Eluate)
- Case Study A4 - Summary of Panels, Phenotyping, and Exclusion Cells
- Case Study A4 - Post-investigation Crossmatch Results
- Case Study A4 - Summary
- Case Study A4 - Answer (Question 1)
- Case Study A4 - Answer (Question 2)
- Case Study A4 - Answer (Question 3)
- Case Study A4 - Answer (Question 4)
- Case Study A4 - Answer (Question 5)
- Case Study A4 - Answer (Question 6)
- Case Study A4 - Antibody Identification (Eluate) - Answer (Question 1)
- Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Question 1)
- Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Exclusion 1)
- Case Study A4 - Summary of Panels, Phenotyping and Exclusion Cells - Answer (Exclusion 2)
- Case Study A4 - Patient Phenotyping - Answer (Question 1)
- Case Study A4 - Patient's Phenotyping - Answer (Question 2)
- Case Study A4 - Antigen Phenotypes
- Case A4 - Answer (Post-transfusion antibody Identification)
- Case A3: Multiple Antibodies in a Mother Delivering Twins
- Case Study A3 - Initial Crossmatch Results
- Case Study A3 - Antibody Identification
- Case Study A3 - Phenotyping
- Case Study A3 - Summary of Panel, Phenotyping, and Exclusion Cells
- Case Study A3 - Crossmatch Results (Post-Antibody Investigation)
- Case Study A3 - Antigen Phenotypes
- Case Study A3 - Twin A Blood Grouping and DAT Results
- Case Study A3 - Twin A Panel Results (Eluate)
- Case Study A3 - Twin A Phenotyping
- Case Study A3 - Twin B Blood Grouping and DAT Results
- Case Study A3 - Twin B Panel Results (Eluate)
- Case Study A3 - Twin B Phenotyping
- Case Study A3 - Father's Phenotyping
- Case Study A3 - Summary
- Case Study A3 - Answer (Question 1)
- Case Study A3 - Answer (Question 2)
- Case Study A3 - Answer (Question 3)
- Case Study A3 - Answer (Question 4)
- Case Study A3 - Summary of Panel - Answer (Question 1)
- Case Study A3 - Summary of Panel - Answer (Exclusion 1)
- Case Study A3 - Summary of Panel - Answer (Exclusion 2)
- Case Study A3 - Summary of Panel - Answer (Exclusion 3)
- Case Study A3 - Summary of Panel - Answer (Exclusion 4)
- Case Study A3 - Summary of Panel - Answer (Exclusion 5)
- Case Study A3 - Summary of Panel - Answer (Exclusion 6)
- Case Study A3 - Summary of Panel - Answer (Question 3)
- Case Study A3 - Twin A Panel Results - Answer (Question 1)
- Case Study A3 - Twin B Panel Results - Answer (Question 1)
- Case Study A3 - Answer (Question 1)
- Case A2: Falling Hemoglobin in a Recently Transfused Patient
- Case Study A2 - Initial Type and Screening Results
- Case Study A2 - Type and Screen and DAT Results
- Case Study A2 - Antibody Identification (Panel 1)
- Case Study A2 - Antibody Identification (Panel 2)
- Case Study A2 - Summary of Panels, Selected Cells, and Self Test
- Case Study A2 - Patient Phenotyping (Pretransfusion Phenotyping Specimen)
- Case Study A2 - Summary
- Case Study A2 - Answer (Question 1)
- Case Study A2 - Answer (Question 2)
- Case Study A2 - Answer (Question 3a)
- Case Study A2 - Answer (Question 3b)
- Case Study A2 - Answer (Question 4)
- Case Study A2 - Answer (Question 5)
- Case Study A2 - Summary of Panels - Answer (Question 1)
- Case Study A2 - Answer (Exclusion 1)
- Case Study A2 - Answer (Exculsion 2)
- Case Study A2 - Answer (Exclusion 3)
- Case Study A2 - Antibody Identification (Panel 1) - Answer
- Case Study A2 - Antibody Identification (Panel 2) - Answer
- Case A1: Unexpected Hemolysis in a Post-Partum Mother
- Case Study A1 - Initial Compatibility Test Results
- Case Study A1 - Compatibility Testing (PEG-IAT) and DAT
- Case Study A1 - Antibody Identification (Plasma)
- Case Study A1 - Antibody Screening (Eluate)
- Case Study A1 - Antibody Identification (Eluate)
- Case Study A1 - Compatibility Testing (Prewarm LISS-IAT)
- Case Study A1 - Patient Phenotyping (Pretransfusion Specimen)
- Case Study A1 - Case Summary
- Case Study A1 - Answer (Question 1)
- Case Study A1 - Answer (Question 2)
- Case Study A1 - Answer (Question 3)
- Case A8: Severe Hemolytic Transfusion Reaction Involving a Student
- Level B Case Studies
- Mini Case B7: Case of a Disappearing Antibody
- Case Study B7 - ABO/Rh and Antibody Screen Results
- Case Study B7 - Cheat Sheet Refresher on Indirect Antiglobulin Test
- Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 1)
- Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 2)
- Case Study B7 - ABO/Rh and Antibody Screen Results - Answer (Question 3)
- Case Study B7 - Crossmatch Results
- Case Study B7 - Crossmatch Results - Answer (Question 4)
- Case Study B7 - DAT Results
- Case Study B7 - DAT Results - Answer (Question 5)
- Case Study B7 - DAT Results - Answer (Question 6)
- Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion)
- Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 7)
- Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 8)
- Case Study B7 - Antibody Investigation Results (Immediately Post-Transfusion) - Answer (Question 9)
- Case Study B7 - Antibody Investigation Results
- Case Study B7 - Answer (Question 13)
- Case Study B7 - Answer (Question 14)
- Case Study B7 - Antibody Investigation Results - Answer (Question 10)
- Case Study B7 - Antibody Identification Results - Answer (Question 11)
- Case Study B7 - Antibody Identification Results - Answer (Question 12)
- Case B6: ABO Group Inconsistent with Records
- Case Study B6 - Initial Pretransfusion Testing Results
- Case Study B6 - Pretransfusion Testing Results
- Case Study B6 - Case Discussion
- Case Study B6 - Case Discussion - Answer (Question 1)
- Case Study B6 - Case Discussion - Answer (Question 2)
- Case Study B6 - Case Discussion - Answer (Question 3)
- Case Study B6 - Case Discussion - Answer (Question 4)
- Case Study B6 - Suggested Answers to Quiz
- Case B5: Severe Delayed Hemolytic Transfusion Reaction
- Case Study B5 - Initial Pretransfusion Testing Results
- Case Study B5 - Reference Laboratory Results
- Case Study B5 - Transfusion Reaction Investigation Results
- Case Study B5 - Case Discussion
- Case Study B5 - Case Discussion - Dosage
- Case Study B5 - Case Discussion - Risk of releasing crossmatch-compatible units that are not antigen-typed
- Case Study B5 - Case Discussion - Answer (Question 1)
- Case Study B5 - Case Discussion - Answer (Question 2)
- Case Study B5 - Case Discussion - Why a patient with an antibody may have a false-negative antibody screen
- Case Study B5 - Case Discussion - Answer (Question 3)
- Case Study B5 - Case Discussion - Answer (Question 4)
- Case Study B5 - Case Discussion - Antibody kinetics in 1o and 2o immune responses
- Case Study B5 - Case Discussion - Comparison of 1o and 2o immune responses
- Case Study B5 - Case Discussion - Answer (Question 5)
- Case Study B5 - Case Discussion - Best practices to prevent DHTR
- Case Study B5 - Case Discussion - Answer (Question 6)
- Case Study B5 - Suggested Answers to Quiz
- Case B4: Acute Hemolysis During Surgery
- Case Study B4 - Case Discussion
- Case Study B4 - Case Discussion - Answer (Question 1)
- Case Study B4 - Case Discussion - Answer (Question 2)
- Case Study B4 - Case Discussion - Answer (Question 3)
- Case Study B4 - Case Discussion - Answer (Question 4)
- Case Study B4 - Case Discussion - Answer (Question 5)
- Case Study B4 - Case Discussion - Answer (Question 6)
- Case Study B4 - Suggested Answers to Quiz
- Case B3: ABO Discrepancy Complicated by Transfusion
- Case Study B3 - Results
- Case Study B3 - Results
- Case Study B3 - Case Discussion
- Case Study B3 - Case Discussion - Answer (Question 1)
- Case Study B3 - Case Discussion - Answer (Question 2)
- Case Study B3 - Case Discussion - Answer (Question 3)
- Case Study B3 - Resolution
- Case Study B3 - Resolution - Results of Mini-Panel
- Case Study B3 - Answer (Question 1)
- Case Study B3 - Answer (Question 2)
- Case Study B3 - Answer (Question 3)
- Case Study B3 - Answer (Question 4)
- Case B2: Missing ABO Antibodies in an Octogenarian
- Case Study B2 - Results
- Case Study B2 - Case Discussion
- Case Study B2 - Case Discussion - Answer (Question 1)
- Case Study B2 - Case Discussion - Investigation Steps
- Case Study B2 - Case Discussion - Answer (Question 2)
- Case Study B2 - Case Discussion - Answer (Question 3)
- Case Study B2 - Case Discussion - Answer (Question 4)
- Case Study B2 - Case Discussion - Answer (Question 5)
- Case Study B2 - Resolution
- Case Study B2 - Answer (Question 1)
- Case Study B2 - Answer (Question 2)
- Case Study B2 - Answer (Question 3)
- Case Study B2 - Answer (Question 4)
- Case Study B2 - Answer (Question 5)
- Case B1: Positive DAT in a Neonate
- Mini Case B7: Case of a Disappearing Antibody
- Level O ("Other") Case Studies
- Case Study O6: Transfusion Reaction Coincidental with Failure to Disobey Physician Orders
- Case Study O6 - Discussion Part 1 - Administering Blood Products
- Case Study O6 - Discussion Part 2 - Investigating Adverse Events
- Case Study O6 - Discussion Part 1 - Answer (Question 1)
- Case Study O6 - Discussion Part 1 - Answer (Question 2)
- Case Study O6 - Discussion Part 1 - Answer (Question 3)
- Case Study O6 - Discussion Part 2 - Answer (Question 1)
- Case Study O6 - Discussion Part 2 - Answer (Question 2)
- Case Study O6 - Discussion Part 2 - Answer (Question 3)
- Case Study O6 - Discussion Part 3 - Scope of Practice Issues
- Case Study O6 - Discussion Part 3 - Answer (Question 1)
- Case Study O6 - Discussion Part 3 - Answer (Question 2)
- Case Study O6 - Discussion Part 4 - Education for interdisciplinary healthcare teams
- Case Study O6 - Discussion Part 3 - Answer (Question 3)
- Case Study O6 - Discussion Part 4 - Answer (Question 1)
- Case Study O6 - Discussion Part 4 - Answer (Question 2)
- Case Study O6 - Discussion Part 4 - Answer (Question 3)
- Case Study O5: Adverse event following plasma transfusion
- Case Study 05 - Discussion Part 4 - Answer (Question 2)
- Case Study 05 - Discussion Part 4 - Answer (Question 3)
- Case Study 05 - Discussion Part 5 - Reporting Adverse Events
- Case Study O5 - Discussion Part 5 - Answer (Question 1)
- Case Study 05 - Discussion Part 1 - Clinical Uses of FFP
- Case Study 05 - Discussion Part 2 - Compatibility Requirements for Plasma
- Case Study 05 - Discussion Part 2 - Answer (Question 1)
- Case Study 05 - Discussion Part 2 - Answer (Question 2)
- Case Study 05 - Discussion Part 2 - Answer (Question 3)
- Case Study 05 - Discussion Part 2 - Answer (Question 4)
- Case Study 05 - Discussion Part 2 - Answer (Question 5)
- Case Study 05 - Discussion Part 3 - Administering Blood Products
- Case Study 05 - Discussion Part 3 - Transfusion Record (Sample)
- Case Study 05 - Discussion Part 3 - Answer (Question 1)
- Case Study 05 - Discussion Part 3 - Answer (Question 2)
- Case Study 05 - Discussion Part 3 - Answer (Question 3)
- Case Study 05 - Discussion Part 3 - Answer (Question 4)
- Case Study 05 - Discussion Part 4 - Investigating Adverse Events
- Case Study 05 - Discussion Part 4 - Answer (Question 1)
- Case Study O4: Death following transfusion of group-specific RBC in a dispensary-only facility
- Case Study 04 - Final Quiz - Answer (Question 1)
- Case Study 04 - Final Quiz - Answer (Question 2)
- Case Study 04 - Final Quiz - Answer (Question 3)
- Case Study 04 - Final Quiz - Answer (Question 4)
- Case Study 04 - Final Quiz - Answer (Question 5)
- Case Study 04 - Final Quiz - Answer (Question 6)
- Case Study 04 - Final Quiz - Answer (Question 7)
- Case Study 04 - Final Quiz - Answer (Question 8)
- Case Study 04 - Final Quiz - Answer (Question 9)
- Case Study 04 - Final Quiz - Answer (Question 10)
- Case Study O4 - Discussion Part 1 - Use of Historical Blood Groups
- Case Study 04 - Discussion Part 1 - Answer (Question 1)
- Case Study 04 - Discussion Part 1 - Answer (Question 2)
- Case Study 04 - Discussion Part 1 - Answer (Question 3)
- Case Study 04 - Discussion Part 1 - Answer (Question 4)
- Case Study O4 - Discussion Part 2 - Issuing blood to the OR
- Case Study 04 - Discussion Part 2 - Answer (Question 1)
- Case Study 04 - Discussion Part 2 - Answer (Question 2)
- Case Study 04 - Discussion Part 2 - Answer (Question 3)
- Case Study O4 - Discussion Part 3 - Medical Consultation
- Case Study O4 - Discussion Part 3 - Answer (Question 1)
- Case Study O4 - Discussion Part 3 - Answer (Question 2)
- Case Study O4 - Discussion Part 3 - Answer (Question 3)
- Case Study O4 - Discussion Part 3 - Answer (Question 4)
- Case Study O4 - Discussion Part 3 - Answer (Question 5)
- Case Study O4 - Discussion Part 4 - Transfusion-Related Responsibilities
- Case Study O4 - Discussion Part 4 - Answer (Question 1)
- Case Study O4 - Discussion Part 4 - Answer (Question 2)
- Case Study O4 - Discussion Part 4 - Answer (Question 3)
- Case Study O4 - Discussion Part 4 - Answer (Question 4)
- Case Study O4 - Discussion Part 5 - Training and Competency Assessment
- Case Study O4 - Discussion Part 5 - Answer (Question 1)
- Case Study O4 - Discussion Part 5 - Answer (Question 2)
- Case Study O4 - Discussion Part 5 - Answer (Question 3)
- Case Study O4 - Discussion Part 5 - Answer (Question 4)
- Case Study O3: Method Validation in the Transfusion Service (TS)
- Case Study O3 - Discussion Part 1 - Introduction to Terminology
- Case Study O3 - Discussion Part 1 - Answer (Question 1)
- Case Study O3 - Discussion Part 1 - Answer (Question 2)
- Case Study O3 - Discussion Part 1 - Answer (Question 3)
- Case Study O3 - Discussion Part 2 - Types of Validation
- Case Study O3 - Discussion Part 2 - Answer (Question 1)
- Case Study O3 - Discussion Part 2 - Answer (Question 2)
- Case Study O3 - Discussion Part 2 - Answer (Question 3)
- Case Study O3 - Discussion Part 3 - When and how extensively to validate a method
- Case Study O3 - Discussion Part 3 - Answer (Question 1)
- Case Study O3 - Discussion Part 3 - Answer (Question 2)
- Case Study O3 - Discussion Part 3 - Answer (Question 3)
- Case Study O3 - Discussion Part 4 - Regulations and Standards
- Case Study O3 - Discussion Part 4 - Answer (Question 1)
- Case Study O3 - Discussion Part 4 - Answer (Question 2)
- Case Study O3 - Discussion Part 4 - Answer (Question 3)
- Case Study O3 - Discussion Part 5 - Validation Examples - Tools & Resources
- Case Study O2: Communication tools for managing patients with special transfusion needs (fludarabine therapy)
- Case Study O2 - Final Quiz - Answer (Question 1)
- Case Study O2 - Final Quiz - Answer (Question 2)
- Case Study O2 - Final Quiz - Answer (Question 3)
- Case Study O2 - Final Quiz - Answer (Question 4)
- Case Study O2 - Final Quiz - Answer (Question 5)
- Case Study O2 - Final Quiz - Answer (Question 6)
- Case Study O2 - Final Quiz - Answer (Question 7)
- Case Study O2 - Final Quiz - Answer (Question 8)
- Case Study O2 - Final Quiz - Answer (Question 9)
- Case Study O2 - Final Quiz - Answer (Question 10)
- Case Study O2 - Discussion Part 1 - Mistake-Proofing Tools
- Case Study O2 - Discussion Part 1 - Answer (Question 1)
- Case Study O2 - Discussion Part 1 - Answer (Question 2)
- Case Study O2 - Discussion Part 1 - Answer (Question 3)
- Case Study O2 - Discussion Part 1 - Answer (Question 4)
- Case Study O2 - Discussion Part 2a - Communication Tools
- Case Study O2 - Discussion Part 2b - Communication Tools
- Case Study O2 - Discussion Part 2b - Answer (Question 1)
- Case Study O2 - Discussion Part 2b - Answer (Question 2)
- Case Study O2 - Discussion Part 2b - Answer (Question 3)
- Case Study O2 - Discussion Part 2b - Answer (Question 4)
- Case Study O2 - Discussion Part 2b - Answer (Question 5)
- Case Study O1: Severe hemolysis in a patient with immune thrombocytopenic purpura who has received intravenous Rh immune globulin*
- Case Study O1 - Final Quiz - Answer (Question 1)
- Case Study O1 - Final Quiz - Answer (Question 2)
- Case Study O1 - Final Quiz - Answer (Question 3)
- Case Study O1 - Final Quiz - Answer (Question 4)
- Case Study O1 - Final Quiz - Answer (Question 5)
- Case Study O1 - Final Quiz - Answer (Question 6)
- Case Study O1 - Final Quiz - Answer (Question 7)
- Case Study O1 - Final Quiz - Answer (Question 8)
- Case Study O1 - Discussion Part 1 - Determining antibody specificity
- Case Study O1 - Discussion Part 1 - Answer (Question 1)
- Case Study O1 - Discussion Part 2 - Immmune thrombocytopenic purpura (ITP)
- Case Study O1 - Discussion Part 2 - Answer (Question 1)
- Case Study O1 - Discussion Part 3 - Intravenous immune globulin (IVIG)
- Case Study O1 - Discussion Part 4 - Intravenous RhIG therapy in ITP
- Case Study O1 - Discussion Part 4 - Answer (Question 1)
- Case Study O1 - Discussion Part 4a - Passive antibodies
- Case Study O1 - Discussion Part 4a - Answer (Question 1)
- Case Study O1 - Discussion Part 4b - Severe hemolysis
- Case Study O1 - Discussion Part 4b - Answer (Question 1)
- Case Study O1 - Figure 2 - Selected cells* (Plasma)
- Case Study O1 - Figure 3 - Antibody Identification Results (Eluate)
- Case Study O1 - Figure 4 - Selected cells* (Eluate)
- Case Study O1 - Figure 3 - Answer (Question 1)
- Case Study O1 - Figure 1. Initial Antibody Identification Results (Plasma)
- Case Study O1 - Discussion Part 4 - Answer-1
- Case Study O6: Transfusion Reaction Coincidental with Failure to Disobey Physician Orders
- Level A Case Studies
- Resources
- For Nurses
- TraQ/PBCO Manuals
- Technical Resource Manual and Competency Companion, 2nd edition
- Laboratory Quality Manual
- Technical Operations Manual
- TMP0001 - Antibody Identification
- TMP0002 - Blood Product Inventory Assessment, Order and Receipt
- TMP0003 - Blood Product Retrieval
- TMP0004 - Crossmatch
- TMP0005 - Derivative Selection & Modification
- TMP0006 - Discard & Expiry
- TMP0007 - Emergency Release for Red Cells
- TMP0008 - Exchange Transfusion
- TMP009 - Issue and Return
- TMP0010 - Mother and Infant Examination
- TMP0011 - Neonatal Red Cell Transfusion
- TMP0012 - Non-Red Cell Component Selection and Modification
- TMP0014 - Pretransfusion Examination
- TMP0015 - Provue® Process
- TMP0016 - Red Cell Modification
- TMP0017 - Redistribution Shipment
- TMP0018 - Sample Send Out and Report Received
- TMP0019 - Transfer Product with Patient
- TMP0020 - Transfusion Committee Review
- TMP0021 - Transfusion Reaction Investigation
- Transfusion Medicine-Related Animations & Videos
- Links
- News
- TraQ's Monthly Newsletter
- Monthly newsletter - April 2019
- Monthly newsletter - March 2019
- Monthly newsletter - February 2019
- Monthly newsletter - January 2019
- Monthly newsletter - December 2018
- Monthly newsletter - November 2018
- Monthly newsletter - October 2018
- Monthly newsletter - September 2018
- Monthly newsletter - August 2018
- Monthly newsletter - July 2018
- Monthly newsletter - October 2016
- Monthly newsletter - April 2015
- Monthly newsletter - March 2015
- Monthly newsletter - February 2015
- Monthly newsletter - January 2015
- Monthly newsletter - December 2014
- Monthly newsletter - November 2014
- Monthly newsletter - October 2014
- Monthly newsletter - September 2014
- Monthly newsletter - August 2014
- Monthly newsletter - July 2014
- Monthly newsletter - June 2014
- Monthly newsletter - May 2014
- Monthly newsletter - April 2014
- Monthly newsletter - March 2014
- Monthly newsletter - February 2014
- Monthly newsletter - May 2015
- Monthly newsletter - June 2015
- Monthly newsletter - September 2016
- Monthly newsletter - August 2016
- Monthly newsletter - July 2016
- Monthly newsletter - June 2016
- Monthly newsletter - May 2016
- Monthly newsletter - April 2016
- Monthly newsletter - March 2016
- Monthly newsletter - February 2016
- Monthly newsletter - January 2016
- Monthly Newsletter - December 2015
- Monthly newsletter - November 2015
- Monthly newsletter - October 2015
- Monthly newsletter - September 2015
- Monthly newsletter - August 2015
- Monthly newsletter - July 2015
- Monthly newsletter - January 2014
- Monthly newsletter - December 2013
- Monthly Newsletter - March 2011
- Monthly newsletter - May 2012
- Monthly newsletter - April 2012
- Monthly newsletter - March 2012
- Monthly newsletter - February 2012
- Monthly newsletter - January 2012
- test-newsletter
- Monthly newsletter - December 2011
- Monthly newsletter - November 2011
- Monthly newsletter - October 2011
- Monthly newsletter - September 2011
- Monthly newsletter - August 2011
- Monthly Newsletter - July 2011
- Monthly Newsletter - June 2011
- Monthly Newsletter - Dec 2010
- Monthly Newsletter - Jan 2011
- Monthly newsletter - July 2012
- Monthly newsletter - August 2012
- [Copy of] Monthly newsletter - November 2013
- Monthly newsletter - November 2013
- Monthly newsletter - October 2013
- Monthly newsletter - September 2013
- Monthly newsletter - August 2013
- Monthly newsletter - July 2013
- Monthly newsletter - June 2013
- Monthly newsletter - May 2013
- Monthly newsletter - April 2013
- Monthly newsletter - March 2013
- Monthly newsletter - February 2013
- Monthly newsletter - January 2013
- Monthly newsletter - December 2012
- Monthly newsletter - November 2012
- Monthly newsletter - October 2012
- Monthly newsletter - September 2012
- Monthly newsletter - November 2016
- Monthly newsletter - December 2016
- Monthly newsletter - January 2017
- Monthly newsletter - February 2017
- Monthly newsletter - March 2017
- Monthly newsletter - April 2017
- Monthly newsletter - May 2017
- Monthly newsletter - June 2017
- Monthly newsletter - July 2017
- Monthly newsletter - August 2017
- Monthly newsletter - September 2017
- Monthly newsletter - October 2017
- Monthly newsletter - November 2017
- Monthly Newsletter - December 2017
- Monthly newsletter - January 2018
- Monthly newsletter - February 2018
- Monthly newsletter - March 2018
- Monthly newsletter - April 2018
- Monthly newsletter - May 2018
- Monthly newsletter - June 2018
- International
- New on TraQ - April 2019 (By topic)
- New on TraQ - Chronological (April 2019)
- New on TraQ - Chronological (April 2019)
- New on TraQ - March 2019 (By topic)
- New on TraQ - Chronological (March 2019)
- New on TraQ - February 2019 (By topic)
- New on TraQ - Chronological (February 2019)
- New on TraQ - January 2019 (By topic)
- New on TraQ - Chronological (January 2019)
- New on TraQ - December 2018 (By topic)
- New on TraQ - Chronological (December 2018)
- New on TraQ - November 2018 (By topic)
- New on TraQ - Chronological (November 2018)
- New on TraQ - October 2018 (By topic)
- New on TraQ - Chronological (October 2018)
- New on TraQ - September 2018 (By topic)
- New on TraQ - Chronological (September 2018)
- New on TraQ - August 2018 (By topic)
- New on TraQ - Chronological (August 2018)
- New on TraQ - July 2018 (By topic)
- New on TraQ - Chronological (July 2018)
- New on TraQ - January 2014 (By topic)
- New on TraQ - Chronological (Nov. 2014)
- New on TraQ - November 2014 (By topic)
- New on TraQ - Chronological (Dec. 2014)
- New on TraQ - December 2014 (By topic)
- New on TraQ - Chronological (Jan. 2015)
- New on TraQ - January 2015 (By topic)
- New on TraQ - Chronological (Feb. 2015)
- New on TraQ - February 2015 (By topic)
- New on TraQ - Chronological (March 2015)
- New on TraQ - March 2015 (By topic)
- New on TraQ - Chronological (April 2015)
- New on TraQ - April 2015 (By topic)
- New on TraQ - Chronological (May 2015)
- New on TraQ - May 2015 (By topic)
- New on TraQ - October 2014 (By topic)
- New on TraQ - Chronological (Oct. 2014)
- New on TraQ - September 2014 (By topic)
- New on TraQ - Chronological (Feb. 2014)
- New on TraQ - Feb. 2014
- New on TraQ - Chronological (March 2014)
- New on TraQ - March 2014 (By topic)
- New on TraQ - Chronological (April 2014)
- New on TraQ - April 2014 (By topic)
- New on TraQ - Chronological (May 2014)
- New on TraQ - May 2014 (By topic)
- New on TraQ - Chronological (June 2012)
- New on TraQ - June 2014 (By topic)
- New on TraQ - Chronological (July 2014)
- New on TraQ - July 2014 (By topic)
- New on TraQ - Chronological (August 2014)
- New on TraQ - August 2014 (By topic)
- New on TraQ - Chronological (Sept. 2014)
- New on TraQ - Chronological (June 2015)
- New on TraQ - June 2015 (By topic)
- New on TraQ - Chronological (April 2016)
- New on TraQ - April 2016 (By topic)
- New on TraQ - Chronological (May 2016)
- New on TraQ - May 2016 (By topic)
- New on TraQ - Chronological (June 2016)
- New on TraQ - June 2016 (By topic)
- New on TraQ - Chronological (July 2016)
- New on TraQ - July 2016 (By topic)
- New on TraQ - Chronological (August 2016)
- New on TraQ - August 2016 (By topic)
- New on TraQ - Chronological (Sept. 2016)
- New on TraQ - September 2016 (By topic)
- New on TraQ - Chronological (Oct. 2016)
- New on TraQ - March 2016 (By topic)
- New on TraQ - Chronological (March 2016)
- New on TraQ - February 2016 (By topic)
- New on TraQ - Chronological (July 2015)
- New on TraQ - July 2015 (By topic)
- New on TraQ - Chronological (August 2015)
- New on TraQ - August 2015 (By topic)
- New on TraQ - Chronological (September 2015)
- New on TraQ - September 2015 (By topic)
- New on TraQ - Chronological (Oct. 2015)
- New on TraQ - October 2015 (By topic)
- New on TraQ - Chronological (November 2015)
- New on TraQ - November 2015 (By topic)
- New on TraQ - Chronological (December 2015)
- New on TraQ - December 2015 (By topic)
- New on TraQ - Chronological (Jan. 2016)
- New on TraQ - January 2016 (By topic)
- New on TraQ - Chronological (Feb. 2016)
- New on TraQ - October 2016 (By topic)
- New on TraQ - Chronological (Jan. 2014)
- New on TraQ - March 2011
- New on TraQ - Chronological (December 2011)
- New on TraQ - December 2011 (By topic)
- New on TraQ - Chronological (Jan. 2012)
- New on TraQ - January 2012 (By topic)
- New on TraQ - Chronological (February 2012)
- February 2012 (By topic)
- New on TraQ - Chronological (March 2012)
- New on TraQ - March 2012 (By topic)
- New on TraQ - Chronological (April 2012)
- New on TraQ - April 2012 (By topic)
- New on TraQ - Chronological (May 2012)
- New on TraQ - May 2012 (By topic)
- New on TraQ - June 2012 (By topic)
- Chronological (June 2012)
- New on TraQ - July 2012 (By topic)
- New on TraQ - November 2011 (By topic)
- New on TraQ - October 2011
- New on TraQ - Archive
- New on TraQ - February 2011
- New on TraQ - Chronological
- New on TraQ (By topic)
- New on TraQ - Chronological (May 2011)
- New on TraQ - May 2011 (By topic)
- New on TraQ - Chronological (June 2011)
- New on TraQ - June 2011 (By topic)
- New on TraQ - Chronological (July 2011)
- New on TraQ - July 2011 (By topic)
- New on TraQ - August 2011 (By topic)
- New on TraQ - chronological (August 2011)
- New on TraQ - chronological (September 2011)
- New on TraQ - September 2011 (By topic)
- New on TraQ - Chronological (Oct. 2011)
- New on TraQ - Chronological (July 2012)
- New on TraQ - July 2012 (By topic)
- New on TraQ - Chronological (May 2013)
- New on TraQ - May 2013 (By topic)
- New on TraQ - Chronological (June 2013)
- New on TraQ - June 2013 (By topic)
- New on TraQ - Chronological (July 2013)
- New on TraQ - July 2013 (By topic)
- New on TraQ - August 2013 (By topic)
- New on TraQ - Chronological (August 2013)
- New on TraQ - Chronological (September 2013)
- New on TraQ - September 2013 (By topic)
- New on TraQ - Chronological (October 2013)
- New on TraQ - October 2013 (By topic)
- New on TraQ - Chronological (Nov. 2013)
- New on TraQ - November 2013 (By topic)
- New on TraQ - Chronological (Dec. 2013)
- New on TraQ - December 2013 (By topic)
- New on TraQ - April 2013 (By topic)
- New on TraQ - Chronological (April 2013)
- New on TraQ - Chronological (August 2012)
- New on TraQ - August 2012 (by topic)
- New on TraQ - Chronological (September 2012)
- New on TraQ - September 2012 (By topic)
- New on TraQ - Chronological (October 2012)
- New on TraQ - October 2012 (By topic)
- New on TraQ - Chronological (November 2012)
- New on TraQ - November 2012 (By topic)
- New on TraQ - Chronological (Dec. 2012)
- New on TraQ - March 2013 (By topic)
- New on TraQ - Chronological (March 2012)
- New on TraQ - February 2013 (By topic)
- New on TraQ - Chronological (Feb. 2012)
- New on TraQ - January 2013 (By topic)
- New on TraQ - Chronological (January 2013)
- New on TraQ - December 2012 (By topic)
- New on TraQ - Chronological (November 2016)
- New on TraQ - November 2016 (By topic)
- New on TraQ - Chronological (Dec. 2016)
- New on TraQ - December 2016 (By topic)
- New on TraQ - Chronological (Jan. 2017)
- New on TraQ - January 2017 (By topic)
- New on TraQ - Chronological (February 2017)
- New on TraQ - February 2017 (By topic)
- New on TraQ - Chronological (March 2017)
- New on TraQ - March 2017 (By topic)
- New on TraQ - Chronological (April 2017)
- New on TraQ - April 2017 (By topic)
- New on TraQ - Chronological (May 2017)
- New on TraQ - May 2017 (By topic)
- New on TraQ - Chronological (June 2017)
- New on TraQ - June 2017 (By topic)
- New on TraQ - Chronological (July 2017)
- New on TraQ - July 2017 (By topic)
- New on TraQ - Chronological (August 2017)
- New on TraQ - August 2017 (By topic)
- New on TraQ - Chronological (Sept. 2017)
- New on TraQ - September 2017 (By topic)
- New on TraQ - Chronological (October 2017)
- New on TraQ - October 2017 (By topic)
- New on TraQ - Chronological (November 2017)
- New on TraQ - November 2017 (By topic)
- New on TraQ - Chronological (Dec. 2017)
- New on TraQ - December 2017 (By topic)
- New on TraQ - Chronological (Jan 2018)
- New on TraQ - January 2018 (By topic)
- New on TraQ - Chronological (February 2018)
- New on TraQ - February 2018 (By topic)
- New on TraQ - Chronological (March 2018)
- New on TraQ - March 2018 (By topic)
- New on TraQ - Chronological (April 2018)
- New on TraQ - April 2018 (By topic)
- New on TraQ - Chronological (May 2018)
- New on TraQ - May 2018 (By topic)
- New on TraQ - May 2018 (By topic)
- New on TraQ - Chronological (June 2018)
- New on TraQ - June 2018 (By topic)
- TraQ's Monthly Newsletter